Pharmacophore-driven identification of PPARγ agonists from natural sources. (Q33744181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Pharmacophore-driven identification of PPARγ agonists from natural sources (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author

Kathrine B Christensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Andreana N Assimopoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xavier Fretté

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Vassilios P Papageorgiou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Irene Kouskoumvekaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Rasmus K Petersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Karsten Kristiansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

11 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

Journal of Computer - Aided Molecular Design

16 January 2020

language of work or name

English

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

107-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Evolution of peroxisome proliferator-activated receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

PPARs: diverse regulators in energy metabolism and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Peroxisome proliferator-activated receptor translational research and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Peroxisome proliferator-activated receptor gamma and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

PPAR gamma and human metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Pharmacophore modeling and parallel screening for PPAR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Discovery of novel PPAR ligands by a virtual screening approach based on pharmacophore modeling, 3D shape, and electrostatic similarity screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Activation of PPARgamma by metabolites from the flowers of purple coneflower (Echinacea purpurea).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Identification of bioactive compounds from flowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Antidiabetic plants and their active constituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

PPAR gamma partial agonist, KR-62776, inhibits adipocyte differentiation via activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

GC-MS analysis of penta- and tetra-cyclic triterpenes from resins of Pistacia species. Part I. Pistacia lentiscus var. Chia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Enhancement of preneoplastic lesion yield by Chios Mastic Gum in a rat liver medium-term carcinogenesis bioassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Chios mastic gum modulates serum biochemical parameters in a human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

The uterotonic activity of compounds isolated from the supercritical fluid extract of Ekebergia capensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Coupling SFE to uterotonic bioassay: an on-line approach to analysing medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

A sugar ester and an iridoid glycoside from Scrophularia ningpoensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-010-9398-5

Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia

21 January 2018

1 reference

12 December 2020

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

12 December 2020

Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity

1 reference

12 December 2020

Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism

1 reference

12 December 2020

The Development of INT131 as a Selective PPARgamma Modulator: Approach to a Safer Insulin Sensitizer

1 reference

12 December 2020

Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial

1 reference

12 December 2020

Thiazolidinediones for the treatment of type 2 diabetes

1 reference

12 December 2020

A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma

1 reference

12 December 2020

Structure-based pharmacophore screening for natural-product-derived PPARgamma agonists

1 reference

12 December 2020

Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).

1 reference

12 December 2020

10.1007/S10822-010-9398-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21069556%20AND%20SRC:MED&resulttype=core&format=json

journals/jcamd/PetersenCAFPKK11

16 January 2020

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference